Page last updated: 2024-12-05

2,5-xylenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5-xylenol : A member of the class of phenols that phenol substituted by methyl groups at positions 2 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7267
CHEMBL ID192591
CHEBI ID191381
SCHEMBL ID92202
MeSH IDM0140425

Synonyms (80)

Synonym
2,5-dmp
3,6-dimethylphenol
3,6-xylenol
2,5-xylenol
95-87-4
2,5-dimethylphenol
wln: qr b1 e1
6-methyl-m-cresol
1-hydroxy-2,5-dimethylbenzene
nsc2599
nsc-2599
p-xylenol
phenol, 2,5-dimethyl-
NCGC00091587-01
2,5-dimethyl phenol
ai3-01551
hsdb 5296
brn 1099260
ccris 722
nsc 2599
1,4-dimethyl-2-hydroxybenzene
1,2,5-xylenol
einecs 202-461-5
fema no. 3595
STK358774
2,5-dimethylphenol, >=99%
2,5-dimethylphenol, analytical standard
2,5-xylenol, >=99%, fg
AC-2517
D0775
2,5-dimethyl-phenol
CHEMBL192591
CHEBI:191381
fema 3595
2-hydroxy-p-xylene
AKOS000119348
A25190
NCGC00091587-02
NCGC00091587-03
tox21_201275
tox21_300326
cas-95-87-4
dtxcid905145
dtxsid6025145 ,
NCGC00254281-01
NCGC00258827-01
2.5-dimethyl phenol
xh3e3564kx ,
unii-xh3e3564kx
4-06-00-03164 (beilstein handbook reference)
ec 202-461-5
FT-0610471
AM20050203
2,5-xylenol [fhfi]
dimethylphenol, 2,5-
xylenol 2,5-dimethylphenol [mi]
gemfibrozil impurity a [ep impurity]
2,5-dimethylphenol [hsdb]
metacresol impurity g [ep impurity]
xylenol 2,5-dimethylphenol
SCHEMBL92202
J-507373
F0001-2283
mfcd00002237
2,5-dimethylphenol, pestanal(r), analytical standard
2,5-dimethylphenol (p-xylenol)
2,5-dimethylphenol 100 microg/ml in methanol
p-2-xylenol
2,5'-xylenol
hydroxy-p-xylene
2,5-xylenol, 8ci
xylenol(2,5-) 1,2,5-xylenol 1,4-dimethyl-2-hydroxybenzene 1-hydroxy-2,5-dimethylbenzene 2,5-dimethyl-pheno
BCP25858
Q26840762
EN300-20194
CCG-302495
BS-42340
E89326
25498-21-9
Z104477216

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Our results show that cresols are more toxic than phenol, that xylenols do not exhibit significantly higher toxicity than cresols, and that trimethylphenols are less toxic than cresols."( Acute toxicity of cresols, xylenols, and trimethylphenols to Daphnia magna Straus 1820.
Devillers, J, 1988
)
0.27
" The cresols were 5-fold more toxic than phenol, whereas 2-ethylphenol and 3,4-xylenol were 11-fold more toxic, and 2,5-xylenol was 34-fold more toxic than phenol."( Toxicity and kinetic parameters of the aerobic biodegradation of the phenol and alkylphenols by a mixed culture.
Acuña-Argüelles, ME; Olguin-Lora, P; Razo-Flores, E, 2003
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
2,5-xylenol and 3,5-xylenol degradation427

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency0.01410.000221.22318,912.5098AID588516
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.47750.000214.376460.0339AID720692
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.71910.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.32760.000229.305416,493.5996AID743069
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID602813Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as rate of NADH oxidation coupled to SERCA-catalyzed ATP hydrolysis at <100 uM by spectroscopic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's3 (23.08)18.2507
2000's5 (38.46)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.26 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index56.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]